- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-3-mer
- Ligands
- 33 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.6: 7 residues within 4Å:- Chain A: W.155, E.156, T.313, H.345, N.347, T.426
- Ligands: NAG-NAG.13
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:E.156
NAG-NAG-BMA.19: 7 residues within 4Å:- Chain E: W.155, E.156, T.313, H.345, N.347, T.426
- Ligands: NAG-NAG.26
1 PLIP interactions:1 interactions with chain E- Hydrophobic interactions: E:E.156
NAG-NAG-BMA.32: 7 residues within 4Å:- Chain I: W.155, E.156, T.313, H.345, N.347, T.426
- Ligands: NAG-NAG.39
1 PLIP interactions:1 interactions with chain I- Hydrophobic interactions: I:E.156
- 3 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN.11: 8 residues within 4Å:- Chain A: V.70, E.227, P.228, L.277, N.278, S.457, S.458
- Ligands: NAG-NAG.10
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN.24: 8 residues within 4Å:- Chain E: V.70, E.227, P.228, L.277, N.278, S.457, S.458
- Ligands: NAG-NAG.23
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN.37: 8 residues within 4Å:- Chain I: V.70, E.227, P.228, L.277, N.278, S.457, S.458
- Ligands: NAG-NAG.36
No protein-ligand interaction detected (PLIP)- 30 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.40: 3 residues within 4Å:- Chain A: G.92, N.93
- Chain B: A.21
Ligand excluded by PLIPNAG.41: 3 residues within 4Å:- Chain A: R.208, N.213, T.214
Ligand excluded by PLIPNAG.42: 3 residues within 4Å:- Chain A: N.317, I.338, Q.453
Ligand excluded by PLIPNAG.43: 4 residues within 4Å:- Chain A: K.350, N.354, T.414, Y.417
Ligand excluded by PLIPNAG.44: 2 residues within 4Å:- Chain A: P.369, N.370
Ligand excluded by PLIPNAG.45: 3 residues within 4Å:- Chain A: N.370, T.372, N.410
Ligand excluded by PLIPNAG.46: 2 residues within 4Å:- Chain B: N.105, K.106
Ligand excluded by PLIPNAG.47: 1 residues within 4Å:- Chain B: N.114
Ligand excluded by PLIPNAG.48: 2 residues within 4Å:- Chain B: E.123, N.126
Ligand excluded by PLIPNAG.49: 3 residues within 4Å:- Chain B: N.100, S.102, H.130
Ligand excluded by PLIPNAG.50: 3 residues within 4Å:- Chain E: G.92, N.93
- Chain F: A.21
Ligand excluded by PLIPNAG.51: 3 residues within 4Å:- Chain E: R.208, N.213, T.214
Ligand excluded by PLIPNAG.52: 3 residues within 4Å:- Chain E: N.317, I.338, Q.453
Ligand excluded by PLIPNAG.53: 4 residues within 4Å:- Chain E: K.350, N.354, T.414, Y.417
Ligand excluded by PLIPNAG.54: 2 residues within 4Å:- Chain E: P.369, N.370
Ligand excluded by PLIPNAG.55: 3 residues within 4Å:- Chain E: N.370, T.372, N.410
Ligand excluded by PLIPNAG.56: 2 residues within 4Å:- Chain F: N.105, K.106
Ligand excluded by PLIPNAG.57: 1 residues within 4Å:- Chain F: N.114
Ligand excluded by PLIPNAG.58: 2 residues within 4Å:- Chain F: E.123, N.126
Ligand excluded by PLIPNAG.59: 3 residues within 4Å:- Chain F: N.100, S.102, H.130
Ligand excluded by PLIPNAG.60: 3 residues within 4Å:- Chain I: G.92, N.93
- Chain J: A.21
Ligand excluded by PLIPNAG.61: 3 residues within 4Å:- Chain I: R.208, N.213, T.214
Ligand excluded by PLIPNAG.62: 3 residues within 4Å:- Chain I: N.317, I.338, Q.453
Ligand excluded by PLIPNAG.63: 4 residues within 4Å:- Chain I: K.350, N.354, T.414, Y.417
Ligand excluded by PLIPNAG.64: 2 residues within 4Å:- Chain I: P.369, N.370
Ligand excluded by PLIPNAG.65: 3 residues within 4Å:- Chain I: N.370, T.372, N.410
Ligand excluded by PLIPNAG.66: 2 residues within 4Å:- Chain J: N.105, K.106
Ligand excluded by PLIPNAG.67: 1 residues within 4Å:- Chain J: N.114
Ligand excluded by PLIPNAG.68: 2 residues within 4Å:- Chain J: E.123, N.126
Ligand excluded by PLIPNAG.69: 3 residues within 4Å:- Chain J: N.100, S.102, H.130
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yang, Y.R. et al., Autologous Antibody Responses to an HIV Envelope Glycan Hole Are Not Easily Broadened in Rabbits. J.Virol. (2020)
- Release Date
- 2020-01-29
- Peptides
- SOSIP.664 gp120,SOSIP.664 gp120: AEI
SOSIP.664 gp41: BFJ
rabbit antibody 13B Fragment antigen binding light chain: CGK
rabbit antibody 13B Fragment antigen binding heavy chain: DHL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AE
CI
GB
BF
DJ
IC
LG
EK
JD
HH
FL
K
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-3-mer
- Ligands
- 33 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 30 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yang, Y.R. et al., Autologous Antibody Responses to an HIV Envelope Glycan Hole Are Not Easily Broadened in Rabbits. J.Virol. (2020)
- Release Date
- 2020-01-29
- Peptides
- SOSIP.664 gp120,SOSIP.664 gp120: AEI
SOSIP.664 gp41: BFJ
rabbit antibody 13B Fragment antigen binding light chain: CGK
rabbit antibody 13B Fragment antigen binding heavy chain: DHL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AE
CI
GB
BF
DJ
IC
LG
EK
JD
HH
FL
K